Summary
- Current Price
- As of today, CLYM price is $10.44, with unknown change on
- Current Price All-Time High
- CLYM price is currently -64.84% below its historical high of $29.69 set on
- Market Cap
- CLYM current market cap is $598M, up +613.45% over the past 365 days
- PE Ratio
- CLYM PE ratio is unknown
- Revenue
- CLYM current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for CLYM has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Climb Bio, Inc. |
| Ticker | NASDAQ: CLYM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | climbbio.com |
| Employees | 28 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $10.44 | |
| Price, 1D Change | - | |
| $598M | ||
| - | ||
| - | ||
| 2.44 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.88 | ||
| EPS, 1Y Change | +42.48% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | ELYM | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.88 | ||
| EPS Estimate | N/A | -$0.87 |
| EPS Est. Change | N/A | +1.71% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $10.44 | |
| Price Target | - | $19.00 |
| Price Tgt. Change | - | +81.99% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.83 | -$0.88 | -6.76% | |
| -$0.87 | N/A | +1.71% | |
| -$1.12 | N/A | -27.15% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $10.44 | |
| $5.02 | ||
| $9.41 | ||
| $6.10 | ||
| $9.62 | ||
| $0.45 | ||
| 2.44 | ||
| $0.89 | ||
| 49.25 | ||
| 90.62% | ||
| 100.17% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.88 | ||
| -$97.00K | ||
| - | ||
| -$67.88M | ||
| - | ||
| -$59.85M | ||
| - | ||
| -$67.79M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 15.16 | ||
| 15.16 | ||
| - | ||
| - | ||
| 46.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.04 | ||
| -8.15 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $160.47M | ||
| $101.08M | ||
| $167.74M | ||
| $105.85M | ||
| $7.27M | ||
| $6.98M | ||
| $541.00K | ||
| $256.00K | ||
| $2.27M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $59.85M | ||
| $67.79M | ||
| $97.00K | ||
| $0.00 | ||
| $97.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$54.36M | ||
| $2.83M | ||
| -$21.00K | ||
| $186.00K | ||
| -$54.54M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| BTIG | → | |
| Chardan Capital | ||
| Oppenheimer | → | |
| Mizuho | ||
| BTIG | → | |
| B. Riley Securities | ||
| Truist Securities | ||
| Raymond James |
Analyst sentiment
Institutional ownership
Screeners with CLYM
FAQ
What is the ticker symbol for Climb Bio, Inc.?
The ticker symbol for Climb Bio, Inc. is NASDAQ:CLYM
Does Climb Bio, Inc. pay dividends?
No, Climb Bio, Inc. does not pay dividends
What sector is Climb Bio, Inc. in?
Climb Bio, Inc. is in the Healthcare sector
What industry is Climb Bio, Inc. in?
Climb Bio, Inc. is in the Biotechnology industry
What country is Climb Bio, Inc. based in?
Climb Bio, Inc. is headquartered in United States
When did Climb Bio, Inc. go public?
Climb Bio, Inc. initial public offering (IPO) was on August 10, 2021
Is Climb Bio, Inc. in the S&P 500?
No, Climb Bio, Inc. is not included in the S&P 500 index
Is Climb Bio, Inc. in the NASDAQ 100?
No, Climb Bio, Inc. is not included in the NASDAQ 100 index
Is Climb Bio, Inc. in the Dow Jones?
No, Climb Bio, Inc. is not included in the Dow Jones index
When was Climb Bio, Inc. last earnings report?
Climb Bio, Inc.'s most recent earnings report was on August 14, 2025
When does Climb Bio, Inc. report earnings?
The date for Climb Bio, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CLYM Official Website climbbio.com
- CLYM Profile on Yahoo Finance finance.yahoo.com/quote/CLYM
- CLYM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clym